Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings

[21] Van Esbroeck M(2014)Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia Clin Infect Dis 58 99-790

[22] Kestens L(2012)Tim-3/Galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma Hepatology 56 1342-152

[23] Fransen K(2016)Serum Galectin-9 and Galectin-3-binding protein in acute dengue virus infection Int J Mol Sci 17 832-1226

[24] Njuguna ANJKWR(2010)A crucial role for Kupffer cell-derived Galectin-9 in regulation of T cell immunity in hepatitis C infection PLoS ONE 5 e9504-undefined

[25] Mpoke S(2011)Influence of Galectin-9/Tim-3 interaction on herpes simplex virus-1 latency J Immunol. 187 5745-undefined

[26] Mbuchi M(2011)T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses Proc Natl Acad Sci USA 108 19001-undefined

[27] Muthami L(2016)Immunological roles of elevated plasma levels of matricellular proteins in Japanese patients with pulmonary tuberculosis Int J Mol Sci 18 19-undefined

[28] Mathaai R(2005)Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART J Med Virol 76 153-undefined

[29] Otieno P(2011)Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals AIDS Res Hum Retroviruses 27 461-undefined

[30] Nyakundi P(2011)Plasma levels of soluble CD14 independently predict mortality in HIV infection J Infect Dis 203 780-undefined

[21] Van Esbroeck M(2014)Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia Clin Infect Dis 58 99-790

[22] Kestens L(2012)Tim-3/Galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma Hepatology 56 1342-152

[23] Fransen K(2016)Serum Galectin-9 and Galectin-3-binding protein in acute dengue virus infection Int J Mol Sci 17 832-1226

[24] Njuguna ANJKWR(2010)A crucial role for Kupffer cell-derived Galectin-9 in regulation of T cell immunity in hepatitis C infection PLoS ONE 5 e9504-undefined

[25] Mpoke S(2011)Influence of Galectin-9/Tim-3 interaction on herpes simplex virus-1 latency J Immunol. 187 5745-undefined

[26] Mbuchi M(2011)T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses Proc Natl Acad Sci USA 108 19001-undefined

[27] Muthami L(2016)Immunological roles of elevated plasma levels of matricellular proteins in Japanese patients with pulmonary tuberculosis Int J Mol Sci 18 19-undefined

[28] Mathaai R(2005)Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART J Med Virol 76 153-undefined

[29] Otieno P(2011)Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals AIDS Res Hum Retroviruses 27 461-undefined

[30] Nyakundi P(2011)Plasma levels of soluble CD14 independently predict mortality in HIV infection J Infect Dis 203 780-undefined